You can start tirzepatide without driving to a clinic
You can start tirzepatide without driving to a clinic. Online here means the visit: intake, a licensed clinician, then a pharmacy if they prescribe. Through Beema, that medicine is compounded tirzepatide when it is legally available and clinically appropriate, not a branded Zepbound or Mounjaro pen. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate.
Tirzepatide is a dual GIP and GLP-1 receptor agonist used in branded form as Mounjaro (diabetes) and Zepbound (chronic weight management). Getting it online should mean a licensed visit, not a vial catalog.
Why people ask for tirzepatide specifically
The percentages below come from clinical trials of FDA-approved branded products. They do not describe compounded tirzepatide, and they are not a promise of individual results. SURMOUNT-1 established large mean weight-loss figures for weekly tirzepatide in obesity. SURMOUNT-5 compared it with semaglutide and found a higher average percent loss for tirzepatide in that trial, with gastrointestinal effects still common. Those data inform conversations. They do not require every Houston or Texas patient to start tirzepatide. Semaglutide remains an evidence-based GLP-1 option. A clinician chooses.
Steps for a lawful online start
Complete intake with your location (Texas, Houston, or any other state), history, and current medicines. Disclose prior GLP-1 use and doses. A licensed provider reviews. If they prescribe, pharmacy fulfillment and shipping follow. Follow-up handles titration. No payment is required to begin Beema intake. No one can promise approval.
If you work heat-heavy jobs in Texas or commute long Houston hours, say so. Delayed gastric emptying plus skipped meals is a common nausea setup. That detail helps the clinician pace titration. It is not a reason to buy an unregulated dual-agonist peptide labeled for research.
Compounded versus branded - status, not a price war
Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate. It is not Zepbound, and it is not interchangeable with that branded product. Beema states that on the commercial page and will not run a branded-versus-compounded value table here. If you prefer an FDA-approved brand, say so on intake; Beema still does not sell those brands.
Where cash-pay numbers live
Compounded tirzepatide pricing: 3-month starter pack - brand-new patients beginning tirzepatide can get doses 1 → 2 → 3 (2.5mg → 5mg → 7.5mg) for $597 over 3 months ($199/month); typically one-time. To be presented this starter price, mark that you are new to GLP-1 when asked during intake. After that, maintenance is $297/mo monthly, $263.67/mo on a 3-month plan (save $100), $249.5/mo on a 6-month plan (save $285), or $232.33/mo annually (save $776). Promo code Tirz100 is a one-time-use code for an additional $100 off 3-, 6-, and 12-month plans at checkout; it can't be combined with a 1-month purchase or the starter pack, and can only be redeemed once per patient. The starter pack and the $100-off promo code can't be used together. Confirm the interactive lockup on the compounded tirzepatide page because plan math is maintained there.
Houston and Texas searches
Tirzepatide Houston and tirzepatide doctor Houston are location queries. Beema can evaluate you in Houston under the same 50-state telehealth model. Read tirzepatide in Houston for heat, storage, and local access. For statewide rules, see tirzepatide in Texas. A Houston search still requires a licensed prescriber and a licensed pharmacy, not a social-media seller. Beema Health serves patients located in the United States only. It is not an international service.
Frequently asked questions
Can I get tirzepatide online?
Does Beema sell Zepbound or Mounjaro online?
I searched tirzepatide Houston and tirzepatide Texas. Do I have to live there?
How well did tirzepatide work in trials?
What is Beema's starter pack?
Is this page Beema's tirzepatide money page?
Sources
- [1] Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022.
- [2] Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). N Engl J Med. 2025.
- [3] Zepbound (tirzepatide) U.S. prescribing information, Eli Lilly.
- [4] U.S. Food and Drug Administration. FDA's concerns with unapproved GLP-1 drugs used for weight loss.
Related education
Program pages
These pages describe Beema's live medical weight-loss offering. They are commercial pages, not this educational article.
Beema's live offering is medical weight-loss care
Licensed providers can evaluate adults in all 50 US states through telehealth. Beema Health serves patients located in the United States only. It is not an international service. A licensed clinician reviews each intake and decides whether any medication is appropriate. Completing an online intake does not guarantee a prescription. Compounded semaglutide is not FDA-approved and is considered only when legally available and clinically appropriate. Compounded tirzepatide is not FDA-approved and is considered only when legally available and clinically appropriate.
Beema Health is a LegitScript-certified website. Certification means the certified site is monitored against LegitScript's healthcare merchant standards. It is not an endorsement of Beema's products, not a statement that compounded medication is safe or FDA-approved, and not a claim about competitors. Beema Health has obtained Google's healthcare certification for prescription-drug advertising in the United States. That certification is about advertising eligibility. It is not a Google endorsement of Beema, of any medication, or of any clinical outcome.

